tm logo
Dead/Abandoned
ABANDONED - NO STATEMENT OF USE FILED

no statement of use filed

on 26 Jun 2023

Last Applicant/ Owned by

7707 Fannin St. Ste. 200

Houston

TX

77054

Serial Number

97110809 filed on 05th Nov 2021

Registration Number

N/A

Correspondent Address

Karen Won

Karen Won

One Financial Center

Boston, MA 02111

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

Logo Mark Trademark Information

Pharmaceutical research and development; Research and development in the pharmaceutical and biotechnology fields; Medical research services in the field of cancer; Medical and scientific research in the field of cancer treatment and diagnosis

Classification Information


Class [042]
Computer & Software Services & Scientific Services


Pharmaceutical research and development; Research and development in the pharmaceutical and biotechnology fields; Medical research services in the field of cancer; Medical and scientific research in the field of cancer treatment and diagnosis

Mark Details


Serial Number

No 97110809

Mark Type

No Service Mark

Attorney Docket Number

No 060851-400

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Design Code(s)

02.01.02 -

Shadows or silhouettes of men

02.11.25 -

Other parts of the human body

15.09.25 -

Electrical circuitry and power hardware and routing devices, including circuitry, chargers, fuses, and controllers, but not including mere cables

Legal History


Show more

Status DateAction Taken
26th Jun 2023ABANDONMENT - NO USE STATEMENT FILED
26th Jun 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
22nd Nov 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
27th Sep 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
27th Sep 2022PUBLISHED FOR OPPOSITION
07th Sep 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
18th Aug 2022EXAMINERS AMENDMENT E-MAILED
18th Aug 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
18th Aug 2022EXAMINERS AMENDMENT -WRITTEN
18th Aug 2022EXAMINER'S AMENDMENT ENTERED